CZ128098A3 - Polymorfní formy látek, podporujících sekreci růstového hormonu a farmaceutický prostředek s jejich obsahem - Google Patents

Polymorfní formy látek, podporujících sekreci růstového hormonu a farmaceutický prostředek s jejich obsahem Download PDF

Info

Publication number
CZ128098A3
CZ128098A3 CZ981280A CZ128098A CZ128098A3 CZ 128098 A3 CZ128098 A3 CZ 128098A3 CZ 981280 A CZ981280 A CZ 981280A CZ 128098 A CZ128098 A CZ 128098A CZ 128098 A3 CZ128098 A3 CZ 128098A3
Authority
CZ
Czechia
Prior art keywords
growth hormone
solution
polymorphic form
carbonyl
ethyl
Prior art date
Application number
CZ981280A
Other languages
Czech (cs)
English (en)
Inventor
Jerome P. Draper
David C. Dubost
Michael J. Kaufman
James A. Mccauley
Jennifer L. Vandrilla
Richard J. Varsolona
Original Assignee
Merck And Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603361.8A external-priority patent/GB9603361D0/en
Application filed by Merck And Co., Inc. filed Critical Merck And Co., Inc.
Publication of CZ128098A3 publication Critical patent/CZ128098A3/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Fodder In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Hydrogenated Pyridines (AREA)
CZ981280A 1995-10-27 1996-10-23 Polymorfní formy látek, podporujících sekreci růstového hormonu a farmaceutický prostředek s jejich obsahem CZ128098A3 (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US590095P 1995-10-27 1995-10-27
GBGB9603361.8A GB9603361D0 (en) 1996-02-16 1996-02-16 Polymorphic forms of a growth hormone secretagogue

Publications (1)

Publication Number Publication Date
CZ128098A3 true CZ128098A3 (cs) 1998-09-16

Family

ID=26308741

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ981280A CZ128098A3 (cs) 1995-10-27 1996-10-23 Polymorfní formy látek, podporujících sekreci růstového hormonu a farmaceutický prostředek s jejich obsahem

Country Status (22)

Country Link
EP (1) EP1019402A1 (et)
JP (1) JP3204266B2 (et)
KR (1) KR19990067098A (et)
CN (1) CN1067687C (et)
AU (1) AU707946B2 (et)
BG (1) BG102476A (et)
BR (1) BR9611229A (et)
CA (1) CA2235371A1 (et)
CO (1) CO4770956A1 (et)
CZ (1) CZ128098A3 (et)
EA (1) EA000528B1 (et)
EE (1) EE9800147A (et)
HK (1) HK1017894A1 (et)
HU (1) HUP9902208A3 (et)
IS (1) IS4721A (et)
NO (1) NO310556B1 (et)
NZ (1) NZ321370A (et)
PL (1) PL327511A1 (et)
SK (1) SK51398A3 (et)
TR (1) TR199800726T2 (et)
WO (1) WO1997015574A1 (et)
YU (1) YU56696A (et)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6046333A (en) * 1996-10-25 2000-04-04 Merck & Co., Inc. Convergent process for the preparation of a growth hormone secretagogue
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
WO2017075535A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ151495A3 (en) * 1992-12-11 1995-12-13 Merck & Co Inc Spiropiperidine derivatives, process of their preparation and a pharmaceutical composition containing thereof

Also Published As

Publication number Publication date
EA000528B1 (ru) 1999-10-28
JP3204266B2 (ja) 2001-09-04
SK51398A3 (en) 1998-12-02
JPH10512295A (ja) 1998-11-24
CO4770956A1 (es) 1999-04-30
EP1019402A1 (en) 2000-07-19
YU56696A (sh) 1999-09-27
CN1205703A (zh) 1999-01-20
NO981867D0 (no) 1998-04-24
NO310556B1 (no) 2001-07-23
MX9803351A (es) 1998-09-30
AU7468696A (en) 1997-05-15
CN1067687C (zh) 2001-06-27
WO1997015574A1 (en) 1997-05-01
EE9800147A (et) 1998-12-15
KR19990067098A (ko) 1999-08-16
NZ321370A (en) 1999-11-29
CA2235371A1 (en) 1997-05-01
EA199800335A1 (ru) 1998-12-24
BG102476A (en) 1999-04-30
BR9611229A (pt) 1999-05-25
HUP9902208A3 (en) 2001-05-28
NO981867L (no) 1998-06-29
AU707946B2 (en) 1999-07-22
PL327511A1 (en) 1998-12-21
HK1017894A1 (en) 1999-12-03
TR199800726T2 (xx) 1998-08-21
HUP9902208A2 (hu) 1999-10-28
IS4721A (is) 1998-04-21

Similar Documents

Publication Publication Date Title
US6123964A (en) Wet granulation formulation of a growth hormone secretagogue
US5767124A (en) Polymorphic forms of a growth hormone secretagogue
DE69332075T2 (de) Spiropiperidine and ihre Homologen, die die Ausschüttung von Wachstumshormonen stimulieren
TWI221153B (en) Tartrate salt of a substituted dipeptide
DE60112753T2 (de) Verbindungen zur stimulation der sekretion von wachstumshormonen
JPH10506914A (ja) 4−複素環式ピペリジンは成長ホルモンの放出を促進する
AU2001266066A1 (en) Growth hormone secretagogues
JP2509147B2 (ja) 成長ホルモンの放出を亢進させるスピロピペリジン及び同族体
CA2234817A1 (en) Wet granulation formulation of a growth hormone secretagogue
KR20020015987A (ko) 성장 호르몬 분비촉진제로서의 신규 아미드 유도체
DE60010711T2 (de) Amido-spiropiperidine promovieren die freisetzung von wachstumshormonen
CZ128098A3 (cs) Polymorfní formy látek, podporujících sekreci růstového hormonu a farmaceutický prostředek s jejich obsahem
MXPA98003351A (en) ot. POLYMORPHIC FORMS OF A GROWTH HORMONE SECRETAGOGUE
BRPI9611229B1 (pt) Polymorphic form of the compound of N- [1 (R) - [(1,2-dihydro-1-methanesulfonyl-spiro [3 H -indol-3,4'-piperdin] -1'-yl) carbonyl] -2- - (phenylmethyl oxy) ethyl] -2-amino-2-methylpropanamide and pharmaceutical composition
CZ20003152A3 (cs) Soli N-methyi-N-((lR)-l-(N-methyl-N-((lR)-l- (methylkarbamoyl)-2-fenylethyl)karbamoyl)-2 (2-naftyl)ethyl)amidu (2E)-5-amino-5-methylhex- 2-enové kyseliny
ZA200208896B (en) Growth hormone secretagogues.
MXPA01004290A (en) Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
MXPA99012100A (en) Tartrate salt of a substituted dipeptide as growth hormone secretagogue
MXPA01002486A (en) Hexahydropyrazolo[4,3-c]pyridine metabolites

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic